Urinary phytoestrogen excretion and postmenopausal breast cancer risk: the multiethnic cohort study.
about
Equol: history, chemistry, and formationThe pros and cons of phytoestrogensThe potential health effects of dietary phytoestrogensDietary flavonoid and lignan intake and breast cancer risk according to menopause and hormone receptor status in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study.Soy intake is associated with lower lung cancer risk: results from a meta-analysis of epidemiologic studies.Isoflavonoids - an overview of their biological activities and potential health benefits.Diet and breast cancer: a systematic review.Dietary isoflavone intake is not statistically significantly associated with breast cancer risk in the Multiethnic Cohort.Soy, red clover, and isoflavones and breast cancer: a systematic reviewEnterolignan-producing phenotypes are associated with increased gut microbial diversity and altered composition in premenopausal women in the United StatesAnalysis of urinary estrogens, their oxidized metabolites, and other endogenous steroids by benchtop orbitrap LCMS versus traditional quadrupole GCMS.Equol production changes over time in pre-menopausal women.Equol inhibits proliferation of human gastric carcinoma cells via modulating Akt pathway.The soy isoflavone equol may increase cancer malignancy via up-regulation of eukaryotic protein synthesis initiation factor eIF4GSoy Isoflavone Genistein-Mediated Downregulation of miR-155 Contributes to the Anticancer Effects of Genistein.Plasma enterolactone and breast cancer risk in the Nurses' Health Study IIDietary factors influence production of the soy isoflavone metabolite s-(-)equol in healthy adultsEquol-producing status, isoflavone intake, and breast density in a sample of U.S. Chinese women.Equol production changes over time in postmenopausal women.Risks and benefits of dietary isoflavones for cancer.Phytochemicals and cancer risk: a review of the epidemiological evidence.Mechanisms underlying the dualistic mode of action of major soy isoflavones in relation to cell proliferation and cancer risks.Metabolism and health effects of phyto-estrogens.Soy Food Intake and Biomarkers of Breast Cancer Risk: Possible Difference in Asian Women?State of the evidence 2017: an update on the connection between breast cancer and the environmentPlasma equol concentration is not associated with breast cancer and fibrocystic breast conditions among women in Shanghai, China.[Dietary isolated isoflavone supplements for peri- and postmenopausal women: risks and questionable benefits].Multigene synergism increases the isoflavone and proanthocyanidin contents of Medicago truncatula.Epidemiological Evidences on Dietary Flavonoids and Breast Cancer Risk: A Narrative ReviewAssociation of isoflavone biomarkers with risk of chronic disease and mortality: a systematic review and meta-analysis of observational studies.Gut microbiota derived metabolites in cardiovascular health and disease.Effects of isoflavones on breast tissue and the thyroid hormone system in humans: a comprehensive safety evaluation
P2860
Q24594674-DA2F0DEB-DD04-4353-AA6F-870AC7F3DCB8Q28387746-34AE3574-CB75-489F-820C-BE52093BA469Q33676455-D10AEE43-70F1-483F-8036-09CB29818942Q34036279-342849B8-A829-4B9F-8263-A66D1CB7EC66Q34071136-5907211C-95F8-4E84-AE09-BD65AE76A563Q34320079-6F4DCDD0-E0AB-4B56-BF35-C0BC8A4339BDQ34437348-81A27DE0-EEC7-4990-A401-10BDA6065616Q34542382-70752C51-F909-4B35-BD55-8F3116CFB201Q34658148-9722A01A-8382-4010-904F-DDCADB5F29EAQ35353462-1506446B-37A6-4427-AC8D-52A460A9762AQ35643914-9EEA33D2-D812-4493-8311-E219C246CCDEQ35870029-7B92EE19-E738-44EC-B499-AFC2420AC24BQ36085584-4309D6F5-C0AC-401F-AC66-8249E51A3F6AQ36451858-5654EC56-C1A2-46B0-9653-110CE5A9372AQ37074134-014DD7AB-28B0-4BAE-BFE5-C7818BFF4302Q37077392-72EC280A-D332-4001-B0CF-45106BCCACF0Q37307326-62313027-07C9-4B7E-8576-87EFC14A3592Q37324699-59CEF3DF-70F4-4F0A-82A2-C87B76387717Q37512708-A879CE13-EB8C-4351-AC2A-3A4E907E4D76Q37857841-AE48852C-DEE2-4802-9A33-72149FF80360Q38033418-57203FA6-5511-407B-88A3-581CBD60CF37Q38061846-14DDA5B8-78DD-469C-A718-04C6CD503048Q38630555-AADB8FFB-2BDF-46D8-B947-9AE0E0D08534Q40441026-0B9918B5-8181-4AFB-A001-FFAE15CED818Q41595188-53344D4D-814F-42B0-BFD5-0F1613D3623AQ41738324-350DBED4-4AAE-44B9-A2FF-550AFD4C4518Q44536906-EEF8172E-453F-49A2-80D4-57BE1B95E154Q46686193-B4D32B90-BCAF-4B37-A28C-7F9765655963Q47137099-5AA26A1C-0C91-42C0-8985-3E360F75C4AEQ47882131-63527627-E22A-45E2-A0A8-8258542A30B8Q55328235-4378EB93-0353-4F8C-BEB1-9DFBB6AC0395Q58726869-32922BE4-0D57-4BB5-85DD-B206B9FC816E
P2860
Urinary phytoestrogen excretion and postmenopausal breast cancer risk: the multiethnic cohort study.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Urinary phytoestrogen excretio ...... the multiethnic cohort study.
@ast
Urinary phytoestrogen excretio ...... the multiethnic cohort study.
@en
Urinary phytoestrogen excretio ...... the multiethnic cohort study.
@nl
type
label
Urinary phytoestrogen excretio ...... the multiethnic cohort study.
@ast
Urinary phytoestrogen excretio ...... the multiethnic cohort study.
@en
Urinary phytoestrogen excretio ...... the multiethnic cohort study.
@nl
prefLabel
Urinary phytoestrogen excretio ...... the multiethnic cohort study.
@ast
Urinary phytoestrogen excretio ...... the multiethnic cohort study.
@en
Urinary phytoestrogen excretio ...... the multiethnic cohort study.
@nl
P2093
P2860
P1476
Urinary phytoestrogen excretio ...... the multiethnic cohort study.
@en
P2093
Abraham M Y Nomura
Adrian A Franke
Kerry K Kakazu
Laurence N Kolonel
Lynne R Wilkens
Marc T Goodman
Yurii B Shvetsov
P2860
P304
P356
10.1158/1940-6207.CAPR-09-0039
P577
2009-09-29T00:00:00Z